Form 8-K - Current report:
SEC Accession No. 0001104659-24-132270
Filing Date
2024-12-30
Accepted
2024-12-30 07:21:02
Documents
13
Period of Report
2024-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431941d1_8k.htm   iXBRL 8-K 33813
  Complete submission text file 0001104659-24-132270.txt   209728

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20241223.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20241223_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20241223_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2431941d1_8k_htm.xml XML 3680
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 241586950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)